Progranulin loss results in sex-dependent dysregulation of peripheral and central immune system in mice.
UF neuroscientists provide preclinical evidence for adoptive cellular therapy as a potential immunotherapy treatment to improve symptoms in genetic form of Parkinson’s.
Dr. Michael Okun featured in USA Today article about study reporting that the number of Americans with Parkinson’s disease is higher than previously estimated.
Study co-authored by Dr. Karen Hegland found sensorimotor training for airway protection improved cough-related outcomes in Parkinson’s patients.
Dr. Dawn Bowers and Rachel Schade led study reporting that dopamine medications improves facial movement and expressions in Parkinson’s.
Amid questions about the late boxing great’s symptoms, UF’s Dr. Michael Okun and colleagues conclude his primary diagnosis was young-onset Parkinson’s disease.
Dr. Michael Okun provides insight into a study by researchers in Switzerland looking into the causes of “freezing” in Parkinson’s.
Drs. Ramzi Salloum and Michael Okun co-authored new JAMA Neurology viewpoint article.
Study co-led by Dr. Michael Okun used temporally optimized patterned stimulation, or TOPS, as a therapy to personalize DBS treatment for Parkinson’s.
Dr. Coralie de Hemptinne honored with Stanley Fahn Junior Faculty Award to advance her research into new neuromodulation strategies for movement disorders.